Get the Stockscreener App
3.12
6.12%
0.18
After Hours:
1.76
-1.36
-43.59%
Biocardia Inc stock is traded at $3.12, with a volume of 157.07K.
It is up +6.12% in the last 24 hours and up +2.30% over the past month.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
See More
Previous Close:
$2.94
Open:
$2.95
24h Volume:
157.07K
Relative Volume:
0.20
Market Cap:
$10.93M
Revenue:
$468.00K
Net Income/Loss:
$-10.34M
P/E Ratio:
-4.6567
EPS:
-0.67
Net Cash Flow:
$-8.94M
1W Performance:
+26.32%
1M Performance:
+2.30%
6M Performance:
-48.89%
1Y Performance:
-51.62%
1-Day Range:
$2.8329
$3.1716
1-Week Range:
$2.34
$3.1716
52-Week Range:
$1.9562
$23.25
Biocardia Inc Stock (BCDA) Company Profile
Name
Biocardia Inc
Sector
Industry
Phone
650-226-0123
Address
320 SOQUEL WAY, SUNNYVALE, CA
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-21 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Stock (BCDA) Latest News
Wall Street SWOT: BioCardia stock rides wave of FDA and CMS support for heart therapy - Investing.com
BioCardia, Inc. (NASDAQ:BCDA) Short Interest Update - Defense World
Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex
A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News
Dawson James downgrades BioCardia Inc. (BCDA) stock to a Neutral - Knox Daily
Harmony Asset Management LLC Trims Stock Position in The Boeing Company (NYSE:BA) - Defense World
The Boeing Company (NYSE:BA) Shares Sold by Edge Capital Group LLC - Defense World
Beck Capital Management LLC Has $1.47 Million Stock Position in The Boeing Company (NYSE:BA) - Defense World
Summit Trail Advisors LLC Boosts Stock Holdings in The Boeing Company (NYSE:BA) - Defense World
The time has not yet come to remove your chips from the table: Biolife Solutions Inc (BLFS) - SETE News
Sei Investments Co. Acquires 11,092 Shares of The Boeing Company (NYSE:BA) - Defense World
Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex
Avoro Capital Advisors LLC Has $77.68 Million Stock Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Discovery Capital Management LLC CT Invests $2.47 Million in BioNTech SE (NASDAQ:BNTX) - MarketBeat
Barrow Hanley Mewhinney & Strauss LLC Boosts Position in Bancolombia S.A. (NYSE:CIB) - MarketBeat
Benjamin F. Edwards & Company Inc. Buys 317 Shares of The Boeing Company (NYSE:BA) - Defense World
Benjamin Edwards Inc. Decreases Stake in Bank of America Co. (NYSE:BAC) - MarketBeat
Inspire Investing LLC Reduces Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Auxier Asset Management Decreases Stock Position in The Boeing Company (NYSE:BA) - Defense World
Comparing BioLargo (NASDAQ:BLGO) and Chemours (NYSE:CC) - Defense World
Sompo Asset Management Co. Ltd. Has $663,000 Stake in The Boeing Company (NYSE:BA) - Defense World
Benjamin Edwards Inc. Has $816,000 Position in The Boeing Company (NYSE:BA) - Defense World
BioLife Solutions (NASDAQ:BLFS) Trading Up 5.8% - Defense World
Bridges Investment Management Inc. Acquires New Position in Bank of America Co. (NYSE:BAC) - MarketBeat
Is Bank of America Corporation (BAC) the Best Affordable Stock To Buy Right Now? - Yahoo Finance
BANCO DO BRASIL/S (OTCMKTS:BDORY) Share Price Crosses Below 200-Day Moving Average of $5.38 - MarketBeat
Hollencrest Capital Management Boosts Holdings in The Boeing Company (NYSE:BA) - Defense World
Bank of America Corp. stock underperforms Friday when compared to competitors - MarketWatch
IPO News: Everything you need to know about BioAge Labs’ IPO - AlphaStreet
Builders FirstSource (NYSE:BLDR) Given New $198.00 Price Target at Bank of America - Defense World
DCF Advisers LLC Buys 250 Shares of The Boeing Company (NYSE:BA) - Defense World
Acadian Asset Management LLC Sells 107,112 Shares of BioNTech SE (NASDAQ:BNTX) - MarketBeat
BioCardia’s $7.2 Million Common Stock Offering - Global Legal Chronicle
Bank of America Corp. stock outperforms competitors on strong trading day - MarketWatch
The Boeing Company (NYSE:BA) Stock Holdings Lowered by Blair William & Co. IL - Defense World
The Boeing Company (NYSE:BA) Shares Bought by Garner Asset Management Corp - Defense World
BioCardia regains Nasdaq compliance, continues listing By Investing.com - Investing.com Canada
Sachin Tendulkar stock jumps 8% after it gets buy call for an upside of 20% - Trade Brains
FirstCry shares surge 7% after BofA, MS initiate coverage, see up to 27% upside scope - The Economic Times
Bank of America Declares Preferred Stock Dividends for Fourth Quarter 2024 - Quantisnow
BCDA’s Stochastic Averages Dip: Analyzing BioCardia Inc.’s Stock Performance - The InvestChronicle
BCDABioCardia, Inc. Latest Stock News & Market Updates - StockTitan
BioCardia regains Nasdaq compliance, continues listing By Investing.com - Investing.com Australia
BioCardia regains Nasdaq compliance, continues listing - Investing.com
BioCardia Regains Full Compliance with Nasdaq Listing Requirements - StockTitan
BLFS (Biolife Solutions Inc) may reap gains as insiders became active recently - Knox Daily
BioCardia Inc. [BCDA] Investment Appeal on the Rise - Knox Daily
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - ForexTV.com
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan
Market Momentum: BioCardia Inc. (BCDA) Registers a -10.10 Decrease, Closing at 2.58 - The Dwinnex
Taking on analysts’ expectations and winning: BioCardia Inc. (BCDA) - SETE News
Biocardia Inc Stock (BCDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):